News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Scientists advance cancer drug design with image of one of key proteins of life
Scientists have pioneered the use of a high-powered imaging technique to picture in exquisite detail one of the central proteins of life – a cellular recycling unit with a role in many diseases.
-vasculature-of-the-mouse-retina-matthew-ashenden-the-icr-2011-1.jpg?sfvrsn=bc35b7e5_2 "(4:3) Vasculature of the mouse retina. Matthew Ashenden / the ICR, 2011-1")
Removing protein slows blood vessel growth in tumours
Scientists from the University of Leeds and The Institute of Cancer Research, London, have discovered a new protein which triggers the growth of blood vessels in breast cancer tumours which have spread to the brain, a common location which breast cancer can spread to.
Re-inventing the finger
In the first of five articles short-listed for the ICR's Mel Greaves Science Writing Prize 2015, the winner Dr Hugh Harvey writes about re-inventing an age-old test for prostate cancer.
New radiotherapy technique could target prostate cancer while reducing side-effects
A new technique for targeting radiotherapy at prostate cancer could improve treatment for aggressive disease that has spread into pelvic lymph nodes.
New use for routine test could improve prediction of breast cancer recurrence
A leading research team has discovered an improved way of predicting risk of breast cancer recurrence following standard five-year hormone treatment using information from a test already being used within the NHS.
New charity Breast Cancer Now acts to eradicate deaths from breast cancer by 2050
A new study analysing tissue from secondary breast cancer patients, collected just hours after they pass away, will open the door to understanding and ultimately stopping the spread of the disease.
Study links gene to aggressive form of brain cancer
Scientists have identified a gene mutation linked to the development of an aggressive form of brain cancer.
Statement about NICE draft guidance on enzalutamide
ICR CEO Professor Paul Workman comments on today’s rejection of enzalutamide for advanced prostate cancer before chemotherapy in draft guidance from NICE.
Mutations disrupting a growth-controlling enzyme implicated in a new childhood overgrowth condition
Scientists have shown that mutations in three genes can alter the function of an important growth-controlling enzyme and cause increased growth and intellectual disability in children
Drug combination controls breast cancer for over twice as long
A new drug delays the progression of advanced breast cancer by over twice as long when used in combination with standard treatment, compared to standard treatment alone, a major clinical trial shows.
Statement about rejection of olaparib by NICE
ICR CEO Professor Paul Workman comments on the decision by NICE to reject olaparib for women with BRCA mutated ovarian cancer.
Sleeping cancer cells can ‘wake up’ after decades
Scientists at the ICR have found genetic evidence that cancer cells can go to sleep – avoiding the effects of treatment – only to ‘wake up’ many years later.
